Skip to content
Screener

Abbott ABT Nutritional Products — Net Sales

Other segment segments

Medical Devices
$5.85B+9.0%
Diagnostic Products
$3.09B+42.3%
Established Pharmaceuticals
$1.5B+8.4%

Similar metrics at other companies

USANA Health Sciences logo
USNACore Nutritional — Net Sales
$204.4M-3.0%
Colgate-Palmolive logo
CLPet Nutrition — Net Sales
$1.2B
Motorola Solutions, Inc. logo
MSIProducts — Net Sales
$1.48B+2.3%
SOL
SOLSProducts — Net Sales
$915M+9.2%
Honeywell International logo
HONProducts — Net Sales
$1.02B-10.8%
Raytheon Technologies logo
RTXProducts — Net Sales
$17.94B+15.4%

Other financials

Income statement

See full
Revenue$12.6B+13.0%
Gross profit$7.3B+15.6%
Operating income$1.7B-17.5%
Net income$928.0M-47.8%
EPS (diluted)$0.53-47.5%

Balance sheet

See full
Cash & equivalents$5.1B-26.6%
Total debt$32.6B+143%
Total equity$51.1B+1.1%
Total assets$109.22B+30.0%

Cash flow

See full
Operating cash flow$2.5B+21.5%
CapEx$497.0M-1.0%
Free cash flow$2.0B+28.9%

Valuation

See full
Market cap$182.9B-19.1%
Enterprise value$210.41B-9.6%
P/E33.7×+17.5×
P/S3.9×-1.3×

Profitability

See full
Gross margin56.6%+0.6pp
Operating margin15.8%-1.7pp
Net margin11.6%-20.8pp
FCF margin16.8%+1.1pp

Returns & leverage

See full
Return on equity10.7%-20.4pp
Debt / equity0.6×+0.4×
Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Abbott’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 4:02 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-050134
(in millions)Three Months Ended June 30, 2026 / U.S.Three Months Ended June 30, 2026 / Int’lThree Months Ended June 30, 2026 / TotalThree Months Ended June 30, 2025 / U.S.Three Months Ended June 30, 2025 / Int’lThree Months Ended June 30, 2025 / Total
Nutritional Products —
Pediatric Nutritionals5255001,0255874671,054
Adult Nutritionals3467731,1193707881,158
Total8711,2732,1449571,2552,212
Diagnostic Products —
Core Laboratory3771,0411,4183511,0071,358
Rapid and Molecular393362755460355815
Cancer Diagnostics89029919

Item 1. Financial Statements and Supplementary Data

FAQ

What is Abbott's nutritional products — net sales?
Abbott (ABT) reported nutritional products — net sales of $2.14B in Q2 2026.
How has Abbott's nutritional products — net sales changed year-over-year?
Abbott's nutritional products — net sales decreased by 3.1% year-over-year, from $2.21B to $2.14B.
What is the long-term trend for Abbott's nutritional products — net sales?
Over 4 years (2021 to 2025), Abbott's nutritional products — net sales has grown at a 0.5% compound annual growth rate (CAGR), from $8.29B to $8.45B.
What does nutritional products — net sales mean?
Represents the total revenue generated from the sale of nutritional products, including infant formula and adult nutritional liquids, after deductions for returns and allowances. This metric reflects the market demand and pricing power for the company's nutritional portfolio within the global healthcare and consumer goods market.

Ask your AI about Abbott's nutritional products — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude